Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer
- 1 February 1981
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 11 (4), 331-338
- https://doi.org/10.1016/0304-3835(81)90099-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]British Journal of Clinical Pharmacology, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansCancer Cell, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- Polymorphism of carbon oxidation of drugs and clinical implications.BMJ, 1978
- Hypotensive response to debrisoquine and hydroxylation phenotypeLife Sciences, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Dietary aflatoxins and liver cancer – a population based study in KenyaBritish Journal of Cancer, 1973
- Association between aflatoxin content of food and hepatoma frequency in UgandaCancer, 1971